News
Thursday, 15/12/11
Abionic among the finalists for the European ACES Academic Enterprise awards
Abionic has been selected as a finalist of the ACES Academic Enterprise Awards by a committee of leading industry officials and academics. Abionic will join the other finalists from universities across Europe to the final judging on February 21st, at the Royal Academy of Science in Brussels, Belgium, in a conference and gala awards ceremony. The Academic Enterprise Awards (ACES) is a pan-European prize that recognizes entrepreneurship at European academic institutions.
Sunday, 30/10/11
See Abionic on Swiss National TV news (only in French)
Thursday, 13/10/11
Abionic ranked 32nd best Swiss Startup in 2011
One hundred experts, all extremely well networked in the Swiss startup scene, have played the role of kingmaker and have selected the current 100 best startups in Switzerland. The experts who determined the Top 100 named a total of several hundred companies. Despite this large number, the firms on the experts’ radar screens are only a small subset of the more than 200,000 companies that have sprung up in Switzerland since 2006. Abionic's team is very proud to have been selected amongst the Top 100 (ranked 32nd best Swiss Startup, 3rd position in the Medtech category).
Wednesday, 12/10/11
Meet us at the Carrefour des Créateurs on Tuesday November 1st, 2011 in Lausanne
Next November 1st, Genilem and its partners organize the 5th Carrefour des Créateurs event, in Beaulieu Lausanne. Abionic is invited to present its products and to discuss Startup fundings.
Thursday, 29/09/11
Cover page for Abionic !
The Economie Région Lausannoise Review published an article on the PERL award and has chosen Abionic for its cover page (see Abionic SA, emblème du succès des Trophées PERL, only in french).
Monday, 19/09/11
Expedition to the Silicon Valley
Abionic participated to the Silicon Valley expedition organized by the IMD business school of Lausanne (http://www.imd.org/). Several EMBA students helped to develop Abionic business strategy.
Wednesday, 29/06/11
Abionic receives the De Vigier 2011 Award
More over 200 companies and investors met today in Solothurn on the occasion of the 23rd award of De Vigier Foundation. Five Swiss companies active in medical technology (Abionic SA), in biotechnology (Malcisbo AG), in information technology (GetYourGuide AG) and robotics (ViSSee Sagl and SkyBotix AG) were recognized and awarded each with CHF 100,000. The evaluation criteria were the original character of the project, its social dimension, its technical and financial feasibility, and the commercial potential.
The canton of Solothurn-based entrepreneur William A. De Vigier wanted to help young Swiss entrepreneurs by providing them with what he has been lacking when he started his own company in 1935: the starting capital. Today, this is still the main obstacle to the realization of an idea as brilliant as it is. Since its creation in 1987, the De Vigier Foundation aims to ensure the active promotion of the economy by financially supporting young Swiss people who have ideas and have the desire to start a business, to make it effective and ensure its growth.
This award is the 11th recognition that Abionic received, which is a record in Switzerland for an early- stage company. Among the awards are: DebioPharm Award, PERL Award (Prix Entreprendre Lausanne Région), KPMG Inspiration grant, Startups.ch Award, Young Entrepreneur Award from the French Advisory Committee for Foreign Trade in Switzerland, VentureKick grants (all 3 stages), Venture Leaders, IMD Startup Competition, FIT grant (Foundation for technical innovation) and finally, Abionic was also selected amongst the 20th best Swiss Business Ideas (Venture 2010).
Monday, 20/06/11
Abionic nominates Tim Dyer as New Member of the Board of Directors
Abionic announced today that Mr. Tim Dyer was nominated member of the Board of Directors.
Tim is co-founder and chief financial officer of Addex Pharmaceuticals where he played a significant role in raising more than CHF260 million in capital including Addex IPO, 3 venture capital rounds and a PIPE transaction. Since founding in 2002 until 2008 he was also responsible for human resources and business development and oversaw the growth of the organization to more than 140 staff and signing of drug development partnerships with Merck & Co., Inc. and Johnson & Johnson.
Prior to joining Addex he spent 10 years with PricewaterhouseCoopers in the UK, Ex-Soviet Union and Switzerland. Tim is a member of the Swiss government innovation promotion agency coaching team and has extensive experience in finance and the building of start-up companies. He is a UK Chartered Accountant and holds a BSc (Hons) in Biochemistry and Pharmacology from the University of Southampton.
Saturday, 26/03/11
National Day of Allergy
National Day of Allergy will be held March 26. The Swiss Centre for Allergy, Asthma and skin (AHA!) will be present on that date in five major shopping malls in Switzerland with information stands. From 10a.m to 4p.m., interested people can obtain advices from specialized medical team and perform a free test of their risk of allergy. Discussion on food allergy and cross-reactions between food allergies and those due to pollen are becoming increasingly important in the public and in the media. National Day of Allergy March 26 is an opportunity to provide extensive information on food allergies.
Monday, 07/03/11
Abionic participated at the 12th MedTech Investing Europe Conference in Lausanne.
The MedTech Investing Europe conference is the leading event in Europe for showcasing cutting-edge medical technology and highlighting the latest opportunities for investors. The objective is to ensure the continued development of the European medical industry, providing; industry intelligence, platforms for innovative medical technology companies and savvy investors, and an ideal environment for business networking. Produced in collaboration with Imperial College London and École Polytechnique Fédérale de Lausanne, this conference brings together industry leaders from across the world. Sponsored by the Canton of Vaud and BioAlps, Abionic had the opportunity to present its products to several investors, consultants and start-ups active in the Medical Technology field.
Tuesday, 01/02/11
Abionic was accepted as member of Alliance Association
The Alliance network brings together eight universities (EPFL, UNIFR, UNIGE, UNIL, UniNE, USI, HES-SO and SUPSI), two university hospitals (CHUV and HUG) and cantonal partner associations. Abionic started working with Alliance in June 2010.
Thursday, 25/11/10
IMD executive MBA students will work on Abionic Business strategies
Every year IMD, which is one of the world's leading Business Schools, searches for the most promising startups it can find to work with their executive MBA and MBA participants. Over the past 13 years over 180 early-stage ventures have profited from this collaboration. Twenty startups were chosen in total this year. This year, Abionic will work with some of the 56 participants of the IMD Executive MBA class and will accompany them to Silicon Valley in September 2011.